Iovance Biotherapeutics, Inc. (IOVA)
3.98
-0.25
(-5.91%)
USD |
NASDAQ |
Jun 08, 15:51
Iovance Biotherapeutics Profit Margin (Quarterly) : -110.7% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -- |
| Neurocrine Biosciences, Inc. | 24.30% |
| Amgen, Inc. | 21.02% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.30% |
| Return on Assets | -38.31% |
| Return on Invested Capital | -46.01% |
| Gross Profit Margin (Quarterly) | 28.55% |
| Operating Margin (Quarterly) | -113.5% |
| Return on Net Operating Assets | -60.65% |